Mitsubishi UFJ Asset Management
INO icon

Mitsubishi UFJ Asset Management’s Inovio Pharmaceuticals INO Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,602
Closed -$104K – 1126
2023
Q1 		$104K Buy
10,602
+769
+8% +$13.1K ﹤0.01% 1088
2022
Q4 		$179K Sell
9,833
-838
-8% -$19K ﹤0.01% 1032
2022
Q3 		$221K Buy
10,671
+129
+1% +$3.3K ﹤0.01% 1012
2022
Q2 		$219K Buy
10,542
+6,805
+182% +$192K ﹤0.01% 1034
2022
Q1 		$161K Buy
3,737
+408
+12% +$18.4K ﹤0.01% 1084
2021
Q4 		$208K Sell
3,329
-427
-11% -$34.2K ﹤0.01% 1077
2021
Q3 		$323K Hold
3,756
– – ﹤0.01% 1003
2021
Q2 		$418K Buy
3,756
+1,083
+41% +$104K ﹤0.01% 980
2021
Q1 		$298K Buy
2,673
+846
+46% +$111K ﹤0.01% 954
2020
Q4 		$194K Buy
1,827
+719
+65% +$95.7K ﹤0.01% 956
2020
Q3 		$154K Buy
1,108
+12
+1% +$2.5K ﹤0.01% 923
2020
Q2 		$355K Buy
+1,096
New +$176K ﹤0.01% 802
2019
Q4 		– Sell
-3,373
Closed -$83K – 1024
2019
Q3 		$83K Buy
3,373
+440
+15% +$13.4K ﹤0.01% 921
2019
Q2 		$103K Buy
2,933
+307
+12% +$12.2K ﹤0.01% 912
2019
Q1 		$118K Buy
2,626
+223
+9% +$11.2K ﹤0.01% 863
2018
Q4 		$123K Buy
2,403
+186
+8% +$11.3K ﹤0.01% 817
2018
Q3 		$148K Buy
+2,217
New +$123K ﹤0.01% 807

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Mitsubishi UFJ Asset Management's INO Position: Q2 2023 in Review

Mitsubishi UFJ Asset Management sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 10,602 shares — an estimated $104K sold.

Mitsubishi UFJ Asset Management first reported a position in INO in Q3 2018 and held it in 17 quarters. The position peaked at $418K in Q2 2021. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

  • Mitsubishi UFJ Asset Management reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 10,602 Inovio Pharmaceuticals shares in Q2 2023, an estimated $104K.
  • Mitsubishi UFJ Asset Management first reported a position in Inovio Pharmaceuticals in Q3 2018 and held it in 17 quarters.
  • Mitsubishi UFJ Asset Management's Inovio Pharmaceuticals position peaked at $418K in Q2 2021.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.